[(2R,4S)-2,4-diphenylpiperidin-1-yl]-[(3S,4R)-4-[2-(1H-pyrazol-2-ium-4-yl)phenyl]pyrrolidin-3-yl]methanone

C31H33N4O+ — CID 59563626

IUPAC[(2R,4S)-2,4-diphenylpiperidin-1-yl]-[(3S,4R)-4-[2-(1H-pyrazol-2-ium-4-yl)phenyl]pyrrolidin-3-yl]methanone
SMILESO=C([C@@H]1CNC[C@H]1c1ccccc1-c1c[nH][nH+]c1)N1CC[C@H](c2ccccc2)C[C@@H]1c1ccccc1
InChIInChI=1S/C31H32N4O/c36-31(29-21-32-20-28(29)27-14-8-7-13-26(27)25-18-33-34-19-25)35-16-15-24(22-9-3-1-4-10-22)17-30(35)23-11-5-2-6-12-23/h1-14,18-19,24,28-30,32H,15-17,20-21H2,(H,33,34)/p+1/t24-,28-,29+,30+/m0/s1
InChIKeyLVOXMTTUBOXEMQ-DQNAVNAOSA-O
MW477.63 g/mol
LogP4.95
Rot. Bonds5

About [(2R,4S)-2,4-diphenylpiperidin-1-yl]-[(3S,4R)-4-[2-(1H-pyrazol-2-ium-4-yl)phenyl]pyrrolidin-3-yl]methanone

[(2R,4S)-2,4-diphenylpiperidin-1-yl]-[(3S,4R)-4-[2-(1H-pyrazol-2-ium-4-yl)phenyl]pyrrolidin-3-yl]methanone (PubChem CID 59563626) has the molecular formula C31H33N4O+ and a molecular weight of 477.63 g/mol. Its IUPAC name is [(2R,4S)-2,4-diphenylpiperidin-1-yl]-[(3S,4R)-4-[2-(1H-pyrazol-2-ium-4-yl)phenyl]pyrrolidin-3-yl]methanone.

Molecular Properties

Compound Name[(2R,4S)-2,4-diphenylpiperidin-1-yl]-[(3S,4R)-4-[2-(1H-pyrazol-2-ium-4-yl)phenyl]pyrrolidin-3-yl]methanone
PubChem CID59563626
Molecular FormulaC31H33N4O+
Molecular Weight477.63 g/mol
Exact Mass477.26
IUPAC Name[(2R,4S)-2,4-diphenylpiperidin-1-yl]-[(3S,4R)-4-[2-(1H-pyrazol-2-ium-4-yl)phenyl]pyrrolidin-3-yl]methanone
SMILESO=C([C@@H]1CNC[C@H]1c1ccccc1-c1c[nH][nH+]c1)N1CC[C@H](c2ccccc2)C[C@@H]1c1ccccc1
InChIInChI=1S/C31H32N4O/c36-31(29-21-32-20-28(29)27-14-8-7-13-26(27)25-18-33-34-19-25)35-16-15-24(22-9-3-1-4-10-22)17-30(35)23-11-5-2-6-12-23/h1-14,18-19,24,28-30,32H,15-17,20-21H2,(H,33,34)/p+1/t24-,28-,29+,30+/m0/s1
InChIKeyLVOXMTTUBOXEMQ-DQNAVNAOSA-O
XLogP4.95
TPSA62.27 Ų
H-Bond Donors2
H-Bond Acceptors2
Rotatable Bonds5
Heavy Atoms36
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500477.63
LogP ≤ 54.95
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 102

Analyze [(2R,4S)-2,4-diphenylpiperidin-1-yl]-[(3S,4R)-4-[2-(1H-pyrazol-2-ium-4-yl)phenyl]pyrrolidin-3-yl]methanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [(2R,4S)-2,4-diphenylpiperidin-1-yl]-[(3S,4R)-4-[2-(1H-pyrazol-2-ium-4-yl)phenyl]pyrrolidin-3-yl]methanone?
The IUPAC name of [(2R,4S)-2,4-diphenylpiperidin-1-yl]-[(3S,4R)-4-[2-(1H-pyrazol-2-ium-4-yl)phenyl]pyrrolidin-3-yl]methanone (CID 59563626) is [(2R,4S)-2,4-diphenylpiperidin-1-yl]-[(3S,4R)-4-[2-(1H-pyrazol-2-ium-4-yl)phenyl]pyrrolidin-3-yl]methanone.
What is the SMILES notation for [(2R,4S)-2,4-diphenylpiperidin-1-yl]-[(3S,4R)-4-[2-(1H-pyrazol-2-ium-4-yl)phenyl]pyrrolidin-3-yl]methanone?
The canonical SMILES for [(2R,4S)-2,4-diphenylpiperidin-1-yl]-[(3S,4R)-4-[2-(1H-pyrazol-2-ium-4-yl)phenyl]pyrrolidin-3-yl]methanone is O=C([C@@H]1CNC[C@H]1c1ccccc1-c1c[nH][nH+]c1)N1CC[C@H](c2ccccc2)C[C@@H]1c1ccccc1.
What is the InChIKey of [(2R,4S)-2,4-diphenylpiperidin-1-yl]-[(3S,4R)-4-[2-(1H-pyrazol-2-ium-4-yl)phenyl]pyrrolidin-3-yl]methanone?
The InChIKey is LVOXMTTUBOXEMQ-DQNAVNAOSA-O. The full InChI is InChI=1S/C31H32N4O/c36-31(29-21-32-20-28(29)27-14-8-7-13-26(27)25-18-33-34-19-25)35-16-15-24(22-9-3-1-4-10-22)17-30(35)23-11-5-2-6-12-23/h1-14,18-19,24,28-30,32H,15-17,20-21H2,(H,33,34)/p+1/t24-,28-,29+,30+/m0/s1.
What are the key properties of [(2R,4S)-2,4-diphenylpiperidin-1-yl]-[(3S,4R)-4-[2-(1H-pyrazol-2-ium-4-yl)phenyl]pyrrolidin-3-yl]methanone?
[(2R,4S)-2,4-diphenylpiperidin-1-yl]-[(3S,4R)-4-[2-(1H-pyrazol-2-ium-4-yl)phenyl]pyrrolidin-3-yl]methanone has a molecular weight of 477.63 g/mol, XLogP of 4.95, 5 rotatable bonds, 2 hydrogen bond donors, and 2 hydrogen bond acceptors.
Where does this data come from?
All data for [(2R,4S)-2,4-diphenylpiperidin-1-yl]-[(3S,4R)-4-[2-(1H-pyrazol-2-ium-4-yl)phenyl]pyrrolidin-3-yl]methanone is sourced from PubChem (CID 59563626), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).